Etoricoxib/Cyanocobalamin

依托考昔/维生素B12

Report date: 2024/12/25 14:58:05

Base Information

Drug NameEtoricoxib/Cyanocobalamin
Drug Alias NameEtori+Cyano
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitorsMethylmalonyl-CoA Mutase stimulants
TargetsCyclooxygenase-2Methylmalonyl-CoA Mutase
Therapy Area/IndicationsLow Back Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMexico
CombinationsYes EtoricoxibCyanocobalamin
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Silanes Sa De Cv
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLow Back Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A